The University of Pittsburgh is recognized nationally for its clinical, translational, and basic research programs in rheumatology. In partnership with UPMC, one of the nation’s leading academic medical centers, Pitt drives discovery and elevates patient care at every level. With expertise in scleroderma, myositis, systemic lupus erythematosus, Sjögren’s disease, vasculitis, and autoinflammatory disorders, Pitt researchers and clinicians are pioneering advances that define the future of rheumatic disease care.
At ACR Convergence 2026, experience firsthand the depth and breadth of discovery happening at the University of Pittsburgh. Our faculty and researchers will be highly visible across Orlando, presenting original findings, sharing clinical insights, and forging new collaborations with colleagues from around the world. Connect with our investigators and discover how Pitt can be your partner in solving the most pressing challenges in rheumatology.
